| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/11/1993 | US5210025 Culturing escherichia coli transformed with genetic vectors in the presence of transcriptional inducing agents |
| 05/11/1993 | US5210017 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/11/1993 | US5209929 Immunization against Babesiosis using purified merozoite surface antigens of Basesia bigemina |
| 05/11/1993 | CA1317557C Breast tumor-associated antigen and monoclonal antibodies specific thereto |
| 05/11/1993 | CA1317544C Method for labeling antibodies with a metal ion |
| 05/09/1993 | WO1993009247A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 05/09/1993 | WO1993009239A1 Adeno-associated virus-2 basal vectors |
| 05/09/1993 | CA2100060A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 05/09/1993 | CA2082226A1 Polypeptide, dna fragment encoding the same, drug composition containing the same and process for producing the same |
| 05/09/1993 | CA2081952A1 Recombinant dna sequences and plasmids for cellular immunity vaccines from bacterial toxin-antigen conjugates, and methods of their use |
| 05/09/1993 | CA2081867A1 8-hydroxy-2h-dibenz¬b,f|azepin-2-one dyes |
| 05/08/1993 | WO1993009253A1 Epitope mapping ot the c33c region of hcv |
| 05/08/1993 | CA2099883A1 Epitope mapping of the c33c region of hcv |
| 05/07/1993 | CA2082217A1 Expression of mature proteinase 2a, the partial purification thereof and preparation of substrates having an inhibitory effect |
| 05/06/1993 | DE4136087A1 Neues thrombininhibitorisches protein aus zecken Tick novel thrombin protein from |
| 05/05/1993 | WO1993009252A1 Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay |
| 05/05/1993 | EP0540457A1 Improvements in Borrelia burgdorferi diagnosis and prophylaxis |
| 05/05/1993 | EP0540135A2 Attenuated measles vaccine virus strain containing specific nucleotide sequence and a method for its absolute identification |
| 05/05/1993 | EP0540128A1 Nematode vaccine |
| 05/05/1993 | EP0540065A1 Retinoic acid receptor composition |
| 05/05/1993 | EP0540064A1 Apoaequorin peptides, recombinant DNA vectors capable of expressing the same and microorganisms containing said vectors |
| 05/05/1993 | EP0539748A1 Polypeptides capable of binding to heavy chains of IL-2 receptors |
| 05/05/1993 | EP0539590A1 Plasmid containing dna which codes for the amino acid sequence of tcf-ii, transformed cell, and production of physiologically active substance by using the same |
| 05/05/1993 | EP0539573A1 Genomic modifications with homologous dna targeting |
| 05/05/1993 | EP0539530A1 Purification directed cloning of peptides |
| 05/05/1993 | EP0539518A1 Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 05/05/1993 | EP0539506A1 Method for treating viral infections using oxidized lipoproteins |
| 05/05/1993 | EP0539492A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 05/05/1993 | EP0539491A1 PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
| 05/05/1993 | EP0539455A1 Multivalent anti-cytokine immunoglobulins |
| 05/05/1993 | EP0539414A1 Stable and bioactive modified somatotropins |
| 05/05/1993 | EP0539395A1 IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA) |
| 05/05/1993 | EP0527806A4 Epithelins: novel cysteine - rich growth modulating proteins |
| 05/05/1993 | EP0515569A4 Calcium channel compositions and methods |
| 05/05/1993 | EP0511302A4 Cytotoxic cell-specific protease-related molecules and methods |
| 05/05/1993 | EP0500799A4 Particle-mediated transformation of animal tissue cells |
| 05/05/1993 | EP0491867A4 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 05/05/1993 | EP0486526A4 Tumour necrosis factor binding ligands |
| 05/05/1993 | EP0289584B1 Wound healing and bone regeneration |
| 05/05/1993 | EP0211077B1 Metalloproteinase inhibitor sequence recombinant vector system for using same and recombinant-dna method for the manufacture of same |
| 05/05/1993 | CN1071586A Receptor of mutation growth factor use as pharmaceutical and application for treating cancer |
| 05/05/1993 | CN1071585A Methods of treatment of motor neuron diseases using members of bdnf/nt-3/ngf family of molecule |
| 05/05/1993 | CN1020473C Dna clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
| 05/05/1993 | CN1020472C Mammalian interleukin-4 |
| 05/05/1993 | CA2099367A1 Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay |
| 05/05/1993 | CA2081990A1 Antibodies specific for rar-gamma or a specific isoform of rar-gamma |
| 05/04/1993 | US5208326 8-hydroxy-2h-dibenz(b,f)azepin-2-one dyes |
| 05/04/1993 | US5208321 Labeled antigens |
| 05/04/1993 | US5208320 Cyclic Adenylate Monophosphate |
| 05/04/1993 | US5208220 Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase |
| 05/04/1993 | US5208219 Method for inducing bone growth |
| 05/04/1993 | US5208218 T cell growth factor glycoproteins |
| 05/04/1993 | US5208217 Hepatospecific insulin analogues |
| 05/04/1993 | US5208144 Genetic engineering and hybridization |
| 05/04/1993 | US5208041 Essentially pure human parathyroid hormone |
| 05/04/1993 | US5208021 Method of preparing diphtheria immunotoxins |
| 05/04/1993 | US5208017 Larvicides |
| 05/04/1993 | CA1317412C Urotensin peptides |
| 05/04/1993 | CA1317288C Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 05/04/1993 | CA1317244C Production of biologically active forms of csf using a baculovirus (acnpv)-insect cell expression system |
| 05/01/1993 | CA2417838A1 Method for assaying for a substance that affects an sh-2 phosphorylated ligand regulatory system |
| 05/01/1993 | CA2054608A1 Fusion proteins comprising gm-csf and il-3 |
| 04/29/1993 | WO1993008473A1 Assay for malignant effusions |
| 04/29/1993 | WO1993008469A1 Recombinant calcium channel polypeptides |
| 04/29/1993 | WO1993008306A1 Improvement in borrelia burgdorferi diagnosis and prophylaxis |
| 04/29/1993 | WO1993008303A1 Gene identification |
| 04/29/1993 | WO1993008302A1 Monoclonal antibodies directed against the microtubule-associated protein tau |
| 04/29/1993 | WO1993008300A1 Expression-secretion vectors for the production of biologically active fv fragments |
| 04/29/1993 | WO1993008299A1 Preparation of recombinant borrelia proteins |
| 04/29/1993 | WO1993008298A1 Soluble variants of type i membrane proteins, and methods of using them |
| 04/29/1993 | WO1993008291A1 A novel ribonuclease and its inhibitor |
| 04/29/1993 | WO1993008290A1 Enhanced immunogenicity using leukotoxin chimeras |
| 04/29/1993 | WO1993008286A1 VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI (Bb) |
| 04/29/1993 | WO1993008285A1 Dimorphism genes in fungi |
| 04/29/1993 | WO1993008284A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression |
| 04/29/1993 | WO1993008283A1 Vaccines for actinobacillus pleuropneumoniae |
| 04/29/1993 | WO1993008281A1 cDNA CLONE OF A RAT SEROTONIN TRANSPORTER AND PROTEIN ENCODED THEREBY |
| 04/29/1993 | WO1993008280A1 Recombitope peptides |
| 04/29/1993 | WO1993008279A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 04/29/1993 | WO1993008274A1 Use of thiol redox proteins for reducing disulfide bonds |
| 04/29/1993 | WO1993008267A1 Cell cycle controlling compositions and methods of using same |
| 04/29/1993 | WO1993008264A1 Colostrum fraction, preparation and use thereof as cell culture media supplement |
| 04/29/1993 | WO1993008262A1 A cDNA CLONE ENCODING AN EXPRESSIBLE DOPAMINE TRANSPORTER |
| 04/29/1993 | WO1993008261A1 SEROTONIN TRANSPORTER cDNA |
| 04/29/1993 | WO1993008259A2 Inhibitors of dipeptidyl-aminopeptidase type iv |
| 04/29/1993 | WO1993008215A1 Secreted mac-2-binding glycoprotein |
| 04/29/1993 | WO1993008214A1 cDNA ENCODING THE COCAINE-SENSITIVE BOVINE DOPAMINE TRANSPORTER |
| 04/29/1993 | WO1993008212A1 Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| 04/29/1993 | WO1993008209A1 Diagnosis and treatment of bacterial dysentery |
| 04/29/1993 | WO1993008208A1 Borrelia burgdorferi antigens and uses thereof |
| 04/29/1993 | WO1993008207A1 Novel cytokine |
| 04/29/1993 | WO1993007906A1 Lymphokine gene therapy of cancer |
| 04/29/1993 | WO1993007897A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins |
| 04/29/1993 | WO1993007896A1 E. coli produced immunoglobulin constructs |
| 04/29/1993 | WO1993007895A1 Tripanosoma cruzi heparin-binding protein |
| 04/29/1993 | WO1993007890A1 Treatment of haemophilia |
| 04/29/1993 | WO1993007889A1 Synthesis of human procollagens and collagens in recombinant dna systems |
| 04/29/1993 | WO1993007888A1 Inhib, a factor which inhibits cytokine-activated leukocytes |
| 04/29/1993 | WO1993007872A1 Lysosomal enzyme inhibitors for the treatment of neurodegenerative diseases |
| 04/29/1993 | WO1993000427A3 Neurite growth regulatory factors |